Addeo A - Search Results

1

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.

Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, Dziadziuszko R, de Marinis F, Reck M, Bouchaab H, Peters S. Passaro A, et al. Among authors: addeo a. ESMO Open. 2020 Jun;5(Suppl 3):e000820. doi: 10.1136/esmoopen-2020-000820. ESMO Open. 2020. PMID: 32581069 Free PMC article.

2

Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment.

Del Re M, Addeo A, Passaro A, Petrini I, van Schaik RH, Danesi R. Del Re M, et al. Among authors: addeo a. Pharmacogenomics. 2019 Dec;20(18):1255-1257. doi: 10.2217/pgs-2019-0150. Pharmacogenomics. 2019. PMID: 31829835 No abstract available.

3

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.

Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. Banna G, et al. Among authors: addeo a. ESMO Open. 2020 Apr;5(2):e000765. doi: 10.1136/esmoopen-2020-000765. ESMO Open. 2020. PMID: 32245904 Free PMC article. Review.

4

Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.

Schmid S, Mauti LA, Friedlaender A, Blum V, Rothschild SI, Bouchaab H, Frösch P, Britschgi C, König D, Wannesson L, Janthur WD, Schär S, Demmer I, Addeo A, Jochum W, Früh M. Schmid S, et al. Among authors: addeo a. Cancer Immunol Immunother. 2020 Aug;69(8):1605-1613. doi: 10.1007/s00262-020-02565-0. Epub 2020 Apr 19. Cancer Immunol Immunother. 2020. PMID: 32307579 Free PMC article.

5

Reply to Authors.

Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. Banna G, et al. Among authors: addeo a. ESMO Open. 2020 May;4(Suppl 2):e000809. doi: 10.1136/esmoopen-2020-000809. ESMO Open. 2020. PMID: 32409299 Free PMC article. No abstract available.

6

COVID-19 and lung cancer: risks, mechanisms and treatment interactions.

Addeo A, Obeid M, Friedlaender A. Addeo A, et al. J Immunother Cancer. 2020 May;8(1):e000892. doi: 10.1136/jitc-2020-000892. J Immunother Cancer. 2020. PMID: 32434788 Free PMC article.

7

The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors.

Friedlaender A, Liu SV, Passaro A, Metro G, Banna G, Addeo A. Friedlaender A, et al. Among authors: addeo a. Clin Lung Cancer. 2020 Nov;21(6):e539-e543. doi: 10.1016/j.cllc.2020.04.006. Epub 2020 Apr 30. Clin Lung Cancer. 2020. PMID: 32499210 Review.

8

Cancer and COVID-19: Unmasking their ties.

Addeo A, Friedlaender A. Addeo A, et al. Cancer Treat Rev. 2020 Aug;88:102041. doi: 10.1016/j.ctrv.2020.102041. Epub 2020 Jun 3. Cancer Treat Rev. 2020. PMID: 32516704 Free PMC article. Review.

9

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.

Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, Michielin O, Peters S, Tabernero J, Douillard JY, Pentheroudakis G; Panel members. Curigliano G, et al. Ann Oncol. 2020 Oct;31(10):1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31. Ann Oncol. 2020. PMID: 32745693 Free PMC article.

10

The METeoric rise of MET in lung cancer.

Friedlaender A, Drilon A, Banna GL, Peters S, Addeo A. Friedlaender A, et al. Among authors: addeo a. Cancer. 2020 Nov 15;126(22):4826-4837. doi: 10.1002/cncr.33159. Epub 2020 Sep 5. Cancer. 2020. PMID: 32888330 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters